AMRN
$16.71
Amarin Corp Ads
($.04)
(.24%)
AMRN
Earnings Whisper ®
N/A
3rd Quarter September 2019
Consensus:  ($0.04)
Revenue:  $112.40 Mil
Wednesday
Oct 30
5:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when AMRN reports earnings?
Beat
Meet
Miss

Where is AMRN's stock price going from here?
Up
Flat
Down
Stock chart of AMRN
Analysts
Summary of analysts' recommendations for AMRN
Score
Grade
Pivots
Resistance
$17.48
$17.23
$16.97

$16.72

Support
$16.46
$16.21
$15.95
Tweet
Growth
Description
Amarin Corporation plc is a global pharmaceutical group which develops innovative pharmaceutical products across a range of therapeutic areas utilizing its proprietary advanced oral and transdermal drug delivery technologies.
Peers
Regeneron PharmaceuticalsCelgeneInterCeptVertex PharmaceuticalsMylanBioMarin PharmaceuticalEndo International plcZoetisJohnson & JohnsonBristol-Myers Squibb